Showing results (1321-1330 of 1,337) with videos related to
Sort By:
Pageof 134
Blood|June 20, 2025
Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell LymphomaShinya Rai, Gerben Duns, Fabian Frontzek, et al.Vaccine|August 11, 2021
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020Kelsey L Lytle, Sean P Collins, Leora R Feldstein, et al.Gastroenterology|July 28, 2020
Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2Kathleen E DelGiorno, Chi-Yeh Chung, Vera Vavinskaya, et al.Plos One|February 10, 2025
Identifying priorities and developing collaborative action plans to improve accessible housing practice, policy, and research in CanadaSander L Hitzig, Kirstin E Yuzwa, Linda Weichel, et al.Nature|September 30, 2015
The genomic landscape of response to EGFR blockade in colorectal cancerAndrea Bertotti, Eniko Papp, Siân Jones, et al.Cell|April 9, 2019
A Multiscale Map of the Stem Cell State in Pancreatic AdenocarcinomaNikki K Lytle, L Paige Ferguson, Nirakar Rajbhandari, et al.Experimental Cell Research|August 9, 2015
T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PADurwood B Ray, Gerald A Merrill, Frederic J Brenner, et al.The Annals of Thoracic Surgery|January 8, 2013
Aortic valve and ascending aorta guidelines for management and quality measures: executive summaryLars G Svensson, David H Adams, Robert O Bonow, et al.Nature|April 19, 2019
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoringYu Shi, Weina Gao, Nikki K Lytle, et al.Cancer Discovery|April 13, 2026
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancersHai-Feng Zhang, Edouard De Dreuzy, Yue Zhou Huang, et al.Pageof 134